Primary hyperaldosteronism, a mediator of progressive renal disease in cats

Domestic Animal Endocrinology

Volumn 28, Issue 1, 2005, Pages 85-104

  Javadi, S ^a   Djajadiningrat Laanen, S C ^a   Kooistra, H S ^a   Van Dongen, A M ^a   Voorhout, G ^a   Van Sluijs, F J ^a   Van Den Ingh, T S G A M ^a   Boer, W H ^b   Rijnberk, A ^a  

^a UTRECHT UNIVERSITY   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Cat; Hyperaldosteronism; Hypertension; Hypokalemia; Kidney disease

Indexed keywords

ALDOSTERONE; RENIN;

ADRENAL GLAND; AGING; ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; CASE REPORT; CAT; CAT DISEASE; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; FEMALE; HYPERALDOSTERONISM; HYPERPLASIA; KIDNEY DISEASE; PATHOLOGY; REFERENCE VALUE;

ADRENAL GLANDS; AGING; ALDOSTERONE; ANIMALS; CAT DISEASES; CATS; FEMALE; HYPERALDOSTERONISM; HYPERPLASIA; KIDNEY DISEASES; REFERENCE VALUES; RENIN; TOMOGRAPHY, X-RAY COMPUTED; ULTRASONOGRAPHY;

ANIMALIA; FELIS CATUS;

EID: 11144316056     PISSN: 07397240     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.domaniend.2004.06.010     Document Type: Article

References (58)

1. A.B. Fogo Pathology of progressive nephropathies Curr Opin Neprhol Hypertens 9 2000 241 246
2. G. Wolf Angiotensin II as a renal growth factor Contrib Nephrol Karger 135 2001 92 110
3. M. Ruiz-Ortega, O. Lorenzo, M. Rupérez, V. Esteban, S. Mezzano, and J. Egido Renin-angiotensin system and renal damage: emerging data on angiotensin II as a proinflammatory mediator Contrib Nephrol Karger 135 2001 123 137
4. M. Epstein Aldosterone as a determinant of cardiovascular and renal dysfunction J Royal Soc Med 94 2001 378 383
5. T.H. Hostetter, M.E. Rosenberg, H.N. Ibrahim, and I. Juknevicius Aldosterone and renal disease Curr Opin Nephrol Hypertens 10 2001 105 110
6. I. Feria, I. Pichardo, P. Juárez, V. Ramírez, M.A. González, and N. Uribe Therapeutic benifit of spironolactone in experimental chronic cyclosporine A nephrotoxicity Kidney Int 63 2003 43 52
7. H.M. Syme, P.J. Barber, P.J. Markwell, and J. Elliott Prevalence of systolic hypertension in cats with chronic renal failure at initial evaluation J Am Vet Med Assoc 220 2002 1799 1804
8. S.W. Dow, M.J. Fettman, C.R. Curtis, and R.A. LeCouteur Hypokalemia in cats: 186 cases J Am Vet Med Assoc 194 1989 1604 1608
9. D.J. Polzin, C.A. Osborne, F. Jacob, and S. Ross Chronic renal failure S.J. Ettinger E.C. Feldman Textbook of veterinary internal medicine 5th ed. 2000 WB Saunders Co. Philadelphia 1634 1662
10. S.W. Dow, M.J. Fettman, R.A. LeCouteur, and D.W. Hamar Potassium depletion in cats: renal and dietary influences J Am Vet Med Assoc 191 1987 1569 1575
11. J.L. Jensen, R.A. Henik, M. Brownfield, and J. Armstrong Plasma renin activity and angiotensin I and aldosterone concentrations in cats with hypertension associated with chronic renal disease Am J Vet Res 58 1997 535 540
12. M. Mishina, T. Watanabe, K. Fujii, H. Maeda, Y. Wakao, and M. Takahashi Non-invasive blood pressure measurements in cats: clinical significance of hypertension associated with chronic renal failure J Vet Med Sci 60 1998 805 808
13. A.H. Sparkes, S.M.A. Caney, and T.J. Gruffyd-Jones Inter- and intraindividual variation in Doppler ultrasonic indirect blood pressure measurements in healthy cats J Vet Int Med 13 1999 314 331
14. A. Rijnberk, G. Voorhout, H.S. Kooistra, R.J.M. van der Waarden, F.J. van Sluijs, and J. IJzer Hyperaldosteronism in a cat with metastasised adrenocortical tumour Vet Q 23 2001 38 43
15. A. Rijnberk, A. van Wees, and J.A. Mol Assessment of two tests for the diagnosis of canine hyperadrenocorticism Vet Rec 122 1988 178 180
16. M.M.C. Goossens, H.P. Meyer, G. Voorhout, and E.P.M. Sprang Urinary excretion of glucocorticoids in the diagnosis of hyperadrenocorticism in cats Domest Anim Endocrinol 12 1995 355 362
17. A. Rijnberk, and J.A. Mol Adrenocortical Function. J.J. Kaneko J.W. Harvey M.L. Bruss Clinical Biochemistry of Domestic Animals. 1997 Academic Press San Diego 553 570 Chapter 20
18. A. Rijnberk Protocols for function tests A. Rijnberk Clinical endocrinology of dogs and cats 1996 Kluwer Academic Publishers Dordrecht/Boston 205 212 Chapter 13
19. P. Boer, R.J. Hené, H.A. Koomans, M.G. Nieuwenhuis, G.G. Geyskes, and E.J. Dorhout Mees Blood and extracellular fluid volume in patients with Bartter's syndrome Arch Int Med 143 1983 1902 1905
20. P. Boer, J.H. Sleumer, and M. Spriensma Confirmation of the optimal pH for measuring plasma renin activity in plasma Clin Chem 31 1985 140 150
21. Javadi S, Slingerland LI, van de Beek MG, Boer P, Boer WH, Rijnberk A, Kooistra HS. Plasma renin activity and plasma concentrations of aldosterone, cortisol, ACTH, and α-MSH in healthy household cats. J Vet Int Med 2004; in press.
22. S. Yu, and J.G. Morris Plasma aldosterone concentration of cats Vet J 155 1998 63 68
23. A.D. MacKay, P.E. Holt, and A.H. Sparkes Successful surgical treatment of a cat with primary aldosteronism J Feline Med Surg 1 1999 117 122
24. P.E. Papanek, K.C. Bovee, M.M. Skelton, and A.W. Cowley Chronic pressure-natriuresis relationship in dogs with inherited essential hypertension Am J Hypertens 6 1993 960 967
25. National Research Council (NRC). Nutrient requirements of dogs. National Academy Press, Washington DC, 1986.
26. S. Yu, and J.G. Morris Sodium requirement of adult cats for maintenance based on plasma aldosterone concentration J Nutr 129 1999 419 423
27. Association of American Feed Control Official (AAFCO) nutrient allowances. Official Publication of the Association of American Feed control Officials Inc., Atlanta, GA, USA, 1994.
28. S.M. Flood, J.F. Randolph, Gelzer ARM, and K. Refsal Primary hyperaldosteronism in two cats J Am Anim Hosp Assoc 25 1999 411 416
29. L.E. Moore, D.S. Biller, and T.A. Smith Use of abdominal ultrasonography in the diagnosis of primary hyperaldosteronism in a cat J Am Vet Med Assoc 217 2000 213 215
30. + channels in adrenal zona glomerulosa cells I: characterization of distinct channel types Am J Physiol 263 1992 752 759
31. I. Kifor, T.J. Moore, F. Fallo, E. Sperling, C.Y. Chiou, and A. Menachery Potassium-stimulated angiotensin release from superfused adrenal capsules and enzymatically dispersed cells of the zona glomerulosa Endocrinology 129 1991 823 831
32. R.E. Kolloch, H.J. Kruse, R. Friedrich, M. Ruppert, A. Overlack, and K.O. Stumpe Role of epinephrine-induced hypokalemia in the regulation of renin and aldosterone in humans J Lab Clin Med 127 1996 50 56
33. J.W. Conn Primary aldosteronism J Lab Clin Med 45 1955 661 664
34. K. Hiramatsu, T. Yamada, Y. Yukimura, I. Komiya, K. Ichikawa, and M. Ishihara A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity results in hypertensive patients Arch Int Med 141 1981 1589 1593
35. P.O. Lim, P. Rodgers, K. Cardale, A.D. Watson, and T.M. MacDonald Potentially high prevalence of primary aldosteronism in a primary-care population Lancet 353 1999 1011 1014
36. R.D. Gordon, M.D. Ziesak, T.J. Tunny, M. Stowasser, and S.A. Klemm Evidence that primary aldosteronism may not be uncommon: 12% incidence among antihypertensive drug trial volunteers Clin Exp Pharmacol Physiol 20 1993 296 298
37. J.R. Gill Hyperaldosteronism K.L. Becker Principles and practice of endocrinology and metabolism 3rd ed. 2001 Williams and Wilkins Philadelphia, PA, Lippincott 773 785
38. W.F. Young Pheochromocytoma and primary aldosteronism: diagnostic approaches Endocrinol Metab Clin North Am 26 1997 801 827
39. R. Lifton, R.G. Dluhy, M. Powers, G.M. Rich, S. Cook, and S. Ulick A chimaeric 11 beta-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension Nature 355 1992 262 265
40. L. Pacoe, K.M. Curnow, L. Slutsker, J.M. Connell, P.W. Speiser, and M.I. New Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal crossovers between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 89 1992 8327 8331
41. R.D. Gordon, M. Stowasser, T.J. Tunny, S.A. Klemm, W.L. Finn, and A.L. Krek Clinical and pathological diversity of primary aldosteronism, including a new familial variety Clin Exp Pharmacol Physiol 18 1991 283 286
42. G.T. Griffing, B. Berelowitz, M. Hudson, R. Salzman, J.A. Manson, and S. Aurrechia Plasma immunoreactive gamma melanotropin in patients with idiopathic hyperaldosteronism, aldosterone-producing adenomas, and essential hypertension J Clin Invest 76 1985 163 169
43. I. Miyamori, H. Koshida, T. Matsubara, R. Soma, H. Takasaki, and S. Okamoto Pituitary peptides other than ACTH may not be aldosterone secretagogue in primary aldosteronism Exp Clin Endocrinol 95 1990 323 329
44. P.J. Harvey, L.M. Wing, J. Savage, and D. Molloy The effects of different types and doses of oestrogen replacement therapy on clinic and ambulatory blood pressure and the renin-angiotensin system in normotensive postmenopausal women J Hypertens 17 1999 405 411
45. D.M. Roesch, Y. Tian, W. Zheng, M. Shi, J.G. Verbalis, and K. Sandberg Estradiol attenuates angiotensin-induced aldosterone secretion in ovariectomized rats Endocrinology 141 2000 4629 4636
46. N.J. Schoemaker, K.J. Teerds, J.A. Mol, J.T. Lumeij, J.H.H. Thijssen, and A. Rijnberk The role of luteinizing hormone in the pathogenesis of hyperadenocorticism in neutered ferrets Mol Cell Endocrinol 197 2002 117 125
47. W.H. Boer, H.A. Koomans, and E.J. Dorhout Mees Lithium clearance in mineralocorticoid escape in humans Am J Physiol 252 1987 382 386
48. J.B. Ferris, J.J. Brown, A.M.M. Cumming, R. Fraser, A.F. Lever, and M. Peacock Primary hyperparathyroidism associated with primary hyperaldosteronism Acta Endocrinol 103 1983 365 370
49. L.M. Resnick, and J.H. Laragh Calcium metabolim and parathyroid function in primary aldosteronism Am J Med 78 1985 385 390
50. L.M. Resnick, R.Z. Lewanczuk, J.H. Laragh, and P.K. Pang Parathyroid hypertensive factor-like activity in human essential hypertension: relationship to plasma renin activity and dietary salt sensitivity J Hypertens 11 1993 1235 1241
51. R.Z. Lewanczuk, L.M. Resnick, M.S. Ho, C.G. Benishin, J. Shan, and P.K. Pang Clinical aspects of parathyroid hypertensive factor J Hypertens Suppl 12 1994 11 16
52. L.W. O'Neal, J.M. Kissane, and P.M. Hartroft The kidney in endocrine hypertension. Cushing's syndrome, pheochromocytoma, and aldosteronism Arch Surg 100 1970 498 505
53. D.N. Danforth, M.M. Orlando, F.C. Bartter, and N. Javadpour Renal changes in primary aldosteronism J Urol 117 1977 140 144
54. R.W. Grady, W.M. Kaylor, J-C. Lee, E.L. Bravo, G.N. Gephardt, and A.C. Novick Renal pathology in patients with primary hyperaldosteronism secondary to an adrenal cortical adenoma Urology 48 1996 369 372
55. J.H. Laragh Vasoconstriction volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles Am J Med 55 1973 261 274
56. J.H. Laragh, J.E. Sealey, F.R. Bühler, E.D. Vaughan, H.R. Brunner, and H. Gavras The renin axis and vasoconstriction volume analysis for understanding and treating renovascular and renal hypertension Am J Med 58 1975 4 13
57. W. Oelkers, S. Diederich, and V. Bähr Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage J Clin Endocrinol Metab 85 2000 3266 3270
58. M. Epstein Aldosterone as a mediator of progressive renal disease: pathogenic and clinical implications Am J Kidney Dis 37 2001 677 688